| Verified against primary record | |
| WHO country office | Inaugurated 15 June 2021; previously supported from the WHO Saudi Arabia office[1] |
|---|---|
| Stated reform driver | The sharp increase in the healthcare bill was considered a signal for health sector reforms[1] |
| Universal coverage commitment | Signed the Salalah Declaration in 2018, joining the UHC 2030 compact[1] |
| Medical tourism in WHO regional reporting | Not mentioned[1] |
| Independently reported | |
| Patients sent abroad at state expense | 2,580 in 2012, 3,044 in 2013, 5,531 in 2014 and 11,825 in 2015, on press figures attributed to unnamed sources[2] |
| Reported cost | KD 230 million paid by the Ministry of Health in 2015, attributed to well-informed health sources[2] |
| Source’s own caveat | It states there are no accurate total cost figures[2] |
| Bands apply only to the rows beneath them. The patient and cost figures are placed in the lower band because no official body is recorded as having issued them: the report attributes them to unofficial statistics, unnamed economic reports and unnamed health sources, and names the Ministry of Health only as the payer. The figures are reproduced with that provenance stated rather than presented as official statistics. No typical cost range is given because no official Kuwaiti source publishes prices paid by or for patients. | |
Medical tourism in Kuwait matters chiefly in reverse: Kuwait is widely described as one of the world’s larger state-funded exporters of patients, paying for citizens to be treated overseas. The figures most often quoted for that programme, however, trace back not to the Ministry of Health but to unofficial statistics and unnamed sources, and the report that carries them states plainly that no accurate total cost figures exist.
Figures without an issuing body
A December 2015 report, carried by the Kuwait Times and attributed to the newspaper Al-Qabas, set out the number of patients sent abroad at state expense as 2,580 in 2012, 3,044 in 2013, 5,531 in 2014 and 11,825 in 2015. On cost it gave over 400 million Kuwaiti dinars for 2013, citing unnamed local and international economic reports, and 230 million dinars paid by the Ministry of Health in 2015, citing well-informed health sources.[2]
Three features of that provenance matter. No official body is quoted as issuing any of the statistics; the report describes them as unofficial. The Ministry of Health is named as the payer, not as the source. And the report itself states that there are no accurate total cost figures, which is an unusual and useful admission in a document that nonetheless supplies numbers.[2]
The internal arithmetic is also loose. The report says the number of patients rose by over 500 per cent in four years, but gives no figure for 2011, so the series it prints cannot confirm that claim. Destination countries are not stated at all.[2]
These figures are reproduced here because they are the ones in circulation and because readers encountering them elsewhere are entitled to know where they come from. They are not offered as a measurement of the programme.
What the report alleges about the system
The same report records criticisms attributed to its sources: that some cases sent abroad were not critical enough to warrant it, that lawmakers had interfered in referral decisions, and that allowances were paid to patients on arrival before they had seen a doctor. It also notes that international doctors visit Kuwait monthly.[2]
These are allegations carried by a newspaper and attributed to unnamed sources. They are recorded here as such, and nothing in this entry establishes them.
What the official record does say
A WHO editorial on the expansion of the organisation’s presence in the Gulf records that the WHO country office in Kuwait was inaugurated on 15 June 2021, and that before then WHO support reached Kuwait through desk officers based in the WHO Saudi Arabia country office and the Regional Office. Kuwait signed the Salalah Declaration in 2018, joining the universal health coverage compact, and placed health at the centre of its national strategy.[1]
On the pressures driving reform, the editorial states that the sharp increase in the healthcare bill was considered a signal for health sector reforms, alongside a drift towards hospital-based and tertiary care, demand for advanced technology and costly medicines, and difficulty retaining a sustainable health workforce. Proposed responses include exploring mandatory social or health insurance and strengthening health financing through national health accounts.[1]
A rising healthcare bill is consistent with a large overseas treatment programme, but the editorial does not attribute it to one, gives no numerical health indicators for Kuwait, and makes no mention of medical tourism, foreign patients or patients sent abroad. No inference beyond that is drawn here.[1]
On the regional pattern of outbound travel, an executive briefing published by the United States International Trade Commission recorded that visa restrictions had pushed many Middle Eastern patients towards Southeast Asia, and identified the absence of insurance cover for care abroad as a general constraint on cross-border patient trade. That constraint does not apply where a state pays directly, as Kuwait is reported to do. The briefing states that its views are the author’s rather than the Commission’s.[3]
Limits of the evidence
No official Kuwaiti statistic on the overseas treatment programme was located for this article, and the Ministry of Health’s own website was not reached. The figures given above are a decade old, are attributed by their own publisher to unnamed and unofficial sources, carry no destination breakdown, and sit alongside that publisher’s statement that accurate totals do not exist. Nothing here measures foreign patients treated in Kuwait, for which no figure of any kind was located, and no estimate has been made.
See also
- Government-funded treatment abroad, the category the Kuwaiti programme belongs to
- Medical tourism in Oman, whose ministry names reducing treatment abroad as a goal
- Source markets in medical tourism, the role Kuwait occupies
- Medical tourism statistics, and how figures without an issuing body enter circulation
- Medical travel for unavailable treatments, the usual stated basis for such referrals
References
- Bou Haka, R., Hafeez, A., Attatrah, T. and Al-Mandhari, A. Eastern Mediterranean Region Vision 2023 and expansion of WHO presence at country level: new WHO offices in Bahrain and Kuwait. Eastern Mediterranean Health Journal, volume 27, number 7, 2021. Verified against primary record: the editorial was opened and the inauguration of the Kuwait country office on 15 June 2021, the previous arrangement of support through desk officers at the WHO Saudi Arabia country office and the Regional Office, the 2018 Salalah Declaration and universal health coverage commitment, the statement that the sharp increase in the healthcare bill was considered a signal for health sector reforms, the listed challenges and proposed financing responses, the absence of numerical health indicators for Kuwait, and the absence of any reference to medical tourism or patients treated across borders were read directly. Retrieved 23 October 2026.
- Kuwait Times, attributed to Al-Qabas. 11,000 treated abroad at cost of KD 230m in 2015. 16 December 2015. Independently reported: the article was opened and the annual patient figures for 2012 to 2015, the cost figures for 2013 and 2015 with their attributions, the statement that the statistics are unofficial and that no official body issued them, the identification of the Ministry of Health as payer rather than source, the publisher’s own statement that there are no accurate total cost figures, the absence of any destination breakdown, the unverifiable 500 per cent growth claim, and the criticisms attributed to unnamed sources were read directly. Retrieved 23 October 2026.
- Chambers, A. Trends in U.S. Health Travel Services Trade. Office of Industries, United States International Trade Commission, Executive Briefing on Trade, August 2015. Independently reported: the briefing was opened and the statement that visa restrictions had pushed many Middle Eastern patients towards Southeast Asia, and the identification of the absence of insurance cover for care abroad as a constraint on cross-border patient trade, were read. The briefing states that the views expressed are the author’s and not those of the Commission, and it is placed in this band for that reason. Retrieved 23 October 2026.
Sourcing note: the figures in this entry are reproduced together with their provenance rather than as data, because the publication carrying them states that they are unofficial, names no issuing body, and records that accurate totals do not exist. The allegations about referral practice are identified as allegations attributed to unnamed sources and are not established here. No official Kuwaiti statistic on the overseas treatment programme or on foreign patients treated in Kuwait was located, and nothing has been estimated.